These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11604028)

  • 21. A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-F...C=O interactions.
    Olsen JA; Banner DW; Seiler P; Obst Sander U; D'Arcy A; Stihle M; Müller K; Diederich F
    Angew Chem Int Ed Engl; 2003 Jun; 42(22):2507-11. PubMed ID: 12800172
    [No Abstract]   [Full Text] [Related]  

  • 22. Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design.
    Engh RA; Brandstetter H; Sucher G; Eichinger A; Baumann U; Bode W; Huber R; Poll T; Rudolph R; von der Saal W
    Structure; 1996 Nov; 4(11):1353-62. PubMed ID: 8939759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of inhibitor binding free energies by quantum neural networks. Nucleoside analogues binding to trypanosomal nucleoside hydrolase.
    Braunheim BB; Miles RW; Schramm VL; Schwartz SD
    Biochemistry; 1999 Dec; 38(49):16076-83. PubMed ID: 10587430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structures of thrombin complexed to a novel series of synthetic inhibitors containing a 5,5-trans-lactone template.
    Jhoti H; Cleasby A; Reid S; Thomas PJ; Weir M; Wonacott A
    Biochemistry; 1999 Jun; 38(25):7969-77. PubMed ID: 10387040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
    Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
    Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the active site caging of serine proteases: thrombin and factor Xa.
    Thuring JW; Li H; Porter NA
    Biochemistry; 2002 Feb; 41(6):2002-13. PubMed ID: 11827547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based design of a potent chimeric thrombin inhibitor.
    Morenweiser R; Auerswald EA; van de Locht A; Fritz H; Stürzebecher J; Stubbs MT
    J Biol Chem; 1997 Aug; 272(32):19938-42. PubMed ID: 9242661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S1 subsite in snake venom thrombin-like enzymes: can S1 subsite lipophilicity be used to sort binding affinities of trypsin-like enzymes to small-molecule inhibitors?
    Silva FP; De-Simone SG
    Bioorg Med Chem; 2004 May; 12(10):2571-87. PubMed ID: 15110839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors.
    Schweizer E; Hoffmann-Röder A; Olsen JA; Seiler P; Obst-Sander U; Wagner B; Kansy M; Banner DW; Diederich F
    Org Biomol Chem; 2006 Jun; 4(12):2364-75. PubMed ID: 16763681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin inhibitors with novel P1 binding pocket functionality: free energy of binding analysis.
    Mlinsek G; Oblak M; Hodoscek M; Solmajer T
    J Mol Model; 2007 Jan; 13(1):247-54. PubMed ID: 17013633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
    Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y
    Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bivalent inhibition of human beta-tryptase.
    Schaschke N; Matschiner G; Zettl F; Marquardt U; Bergner A; Bode W; Sommerhoff CP; Moroder L
    Chem Biol; 2001 Apr; 8(4):313-27. PubMed ID: 11325588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor.
    Richardson JL; Kröger B; Hoeffken W; Sadler JE; Pereira P; Huber R; Bode W; Fuentes-Prior P
    EMBO J; 2000 Nov; 19(21):5650-60. PubMed ID: 11060016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The methyl group of N(alpha)(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage.
    Friedrich R; Steinmetzer T; Huber R; Stürzebecher J; Bode W
    J Mol Biol; 2002 Mar; 316(4):869-74. PubMed ID: 11884127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The X-ray crystal structure of thrombin in complex with N alpha-2-naphthylsulfonyl-L-3-amidino-phenylalanyl-4-methylpiperidide: the beneficial effect of filling out an empty cavity.
    Bergner A; Bauer M; Brandstetter H; Stürzebecher J; Bode W
    J Enzyme Inhib; 1995; 9(1):101-10. PubMed ID: 8568562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of ligand conformations in continuum solvent consistent with protein active site topology: application to thrombin.
    Greenidge PA; Mérette SA; Beck R; Dodson G; Goodwin CA; Scully MF; Spencer J; Weiser J; Deadman JJ
    J Med Chem; 2003 Apr; 46(8):1293-305. PubMed ID: 12672230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iterative optimization of high-affinity protease inhibitors using phage display. 2. Plasma kallikrein and thrombin.
    Markland W; Ley AC; Ladner RC
    Biochemistry; 1996 Jun; 35(24):8058-67. PubMed ID: 8672510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
    Wienand A; Ehrhardt C; Metternich R; Tapparelli C
    Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.